Comparison of reported and expected deaths in sildenafil (Viagra) users
Section snippets
Acknowledgements
We thank the members of the Viagra Working Group and others within the FDA who participated in discussions and analyses of these reports, and Joslyn Swann, RPh, who provided IMS HEALTH data. We also thank the physicians, pharmacists, other health care professionals, and consumers who reported these adverse events to the FDA.
References (4)
- et al.
Impotence and its medical and psychosocial correlatesResults of the Massachusetts Male Aging Study
J Urol
(1994) - et al.
DeathsFinal data for 1997
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2002 Excerpta Medica Inc. All rights reserved.